AOD-9604 vs Tesamorelin: Head-to-Head Comparison Table The fastest way to compare AOD-9604 and Tesamorelin is side by side: one is a targeted fat-metabolism fragment with an unproven efficacy record, the other is a GH-axis stimulator with a specific FDA-approved indication
The mTOR pathway regulates cell growth and metabolism, and inhibiting it mimics the effects of caloric restriction, which has been linked to longevity
S., Wang, H., Zhuo, P., Schwartz, J
Vast quantities of research has been published on the benefits of GLP-1s beyond weight loss, but the majority has been on the injectable versions
Medicare covers Mounjaro for diabetic patients, and under the temporary GLP-1 Bridge, now also covers Zepbound (KwikPen only) at $50/month through December 2027